Minimally Invasive Surgery Market Size, Share, Growth, Trends, Report 2022 - 2030
The global minimally invasive surgery market was valued at US$ 8.6 Bn in 2020 and is expected to reach US$ 23.4 by 2030. Minimally invasive surgery (MIS) is a modern technique that enables surgeons to use endoscopic procedures to address diverse issues. Instruments used during minimally invasive surgery (MIS) are small; hence, incisions are smaller than in a traditional open surgery. Additionally, the technology is proving its efficiency in treatment while performing complex surgeries. This drives the global minimally invasive surgery market during the forecast period.
Lowered risk of infection & decreased risk of complications, reduced scarring & quicker recovery with less pain, less expensive than traditional surgery, favorable reimbursement scenario, and rise in cancer awareness & patient support programs by governments are anticipated to propel the global minimally invasive surgery market. The key industry developments, including partnerships, mergers & acquisitions, and collaborations are expected to fuel the growth of the global minimally invasive surgery market
Reduced Scarring and Quicker Recovery with Less Pain to Drive Global Market
Larger incision during open surgery leads to increased pain and longer recovery time. Recovery time following traditional surgical techniques are usually extensive. However, with MIS, recovery time is as short as a few days depending on the surgery type. MIS allows for a shorter hospital stay, with many patients returning home on the same day of surgery. Moreover, due to smaller incisions and less stitches, the healing time after a MIS is quicker than traditional surgery. Pain and postoperative swelling are also less with this technique, allowing patients to be back to their regular activities sooner. Minimally invasive surgery requires smaller incisions; hence, the scars are also smaller than with traditional surgical procedures. This increases patient acceptance and quicker recovery, which in turn boosts the growth of the MIS market.
Rapid Innovations in Compact, Flexible Robotic Systems
Robotic-assisted surgical systems are becoming compact, flexible, and deploy precision in MIS. Med-tech companies in the minimally invasive surgery market are increasing their R&D muscle to develop robotic systems that mimic the features of the daVinci surgical system where the latter is gaining prominence in urology and gynecology. As such, the Senhance surgical robotic system by TransEnterix - a specialist in laparoscopy and robotic-assisted surgery are posing as a rival to the daVinci surgical system.
Manufacturers in the minimally invasive surgery market are increasing the availability of robotic systems that are equipped with standard reusable instruments utilized during oncology and cancer surgery. The proliferation of artificial intelligence (AI) and complex algorithms in robotic systems are contributing to market growth.
Robot-assisted Technology Possesses Potential to Achieve Exact Insertion of Cochlear Implants
Tubular continuum robots hold promising potentials for minimally invasive surgeries. Companies in the minimally invasive surgery market are increasing their production capabilities in such robotic systems, which help to remove tumors in hard-to-reach regions including the pituitary gland. Medical experts at the Hannover Medical School and the International Neuroscience Institute are gaining recognition for increasing their research to innovate in tubular continuum robots.
It is challenging to achieve exact placement and insertion of cochlear implants and ensure the best hearing results. Thus, manufacturers in the minimally invasive surgery market are innovating in the robot-assisted technology, which supports surgeons in such kinds of difficult tasks.
Ergonomically Sound Laparoscopy Devices Provide Best Postural Comfort during MIS
FDA, ISO, and CE clearance have become crucial for supply of MIS tools and instruments. Dex Surgical - a France-based manufacturer of robotized instruments for laparoscopic surgery, is boosting its credibility by complying with regulations of the FDA, CE, and ISO standards for its MIS tools and instruments which help to improve medical outcomes. Companies in the minimally invasive surgery market are setting their collaboration wheels in motion with medical experts and surgeons to acquire patents in MIS devices.
Manufacturers in the minimally invasive surgery market are developing mechatronics system, which involve a combination of micromechanics, software engineering, and embedded electronics to deliver safe and precise MIS procedures that are ergonomically sound during laparoscopic surgeries. Manufacturers are developing articulated handles in laparoscopy devices that provide best postural comfort and eliminate wrist strain.
Market Segmentation
Prominent Regions
In terms of region, the global minimally invasive surgery market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global minimally invasive surgery market in 2020, followed by Europe and Asia Pacific. North America dominated the global MIS market in 2020, owing to a highly developed healthcare sector, increase in awareness among healthcare professionals about Barrett’s esophagus, colorectal cancer, and gastric cancer treatment devices, and continuous evolution of technology. The region offers significant opportunities in the minimally invasive surgery market
The minimally invasive surgery market in Asia Pacific is anticipated to expand at a higher CAGR due to increase in awareness about Barrett’s esophagus, colorectal cancer, and gastric cancer treatment and expansion of the healthcare sector in countries such as China, Japan, and India. Moreover, technological advancements and surge in adoption of Barrett’s esophagus, colorectal cancer, and gastric cancer treatment devices are expected to propel the market in Asia Pacific during the forecast period.
Key Players
Market Segmentation
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Minimally Invasive Surgery Market, By Procedure
7.1. Minimally Invasive Surgery Market, by Procedure Type, 2021-2030
7.1.1. Laparoscopic Surgery
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Robotic Surgery
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Endoscopic Mucosal Resection
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Endoscopic Sub-mucosal Dissection
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Minimally Invasive Surgery Market, By End User
8.1. Minimally Invasive Surgery Market, by End User, 2021-2030
8.1.1. Hospitals
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Clinics
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Ambulatory Surgical Centers
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Minimally Invasive Surgery Market, By Disorder
9.1. Minimally Invasive Surgery Market, by Disorder, 2021-2030
9.1.1. Orthopedic
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Cosmetic & Bariatric
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Gynecological
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Cardiothoracic
9.1.4.1. Market Revenue and Forecast (2016-2030)
9.1.5. Gastrointestinal
9.1.5.1. Market Revenue and Forecast (2016-2030)
9.1.6. Urological
9.1.6.1. Market Revenue and Forecast (2016-2030)
9.1.7. Others
9.1.7.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Minimally Invasive Surgery Market, Regional Estimates and Trend Forecast
10.1.North America
10.1.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.1.2. Market Revenue and Forecast, by End User (2016-2030)
10.1.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.1.4.2. Market Revenue and Forecast, by End User (2016-2030)
10.1.4.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.1.5.2. Market Revenue and Forecast, by End User (2016-2030)
10.1.5.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.2.Europe
10.2.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.2.2. Market Revenue and Forecast, by End User (2016-2030)
10.2.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.2.4.2. Market Revenue and Forecast, by End User (2016-2030)
10.2.4.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.2.5.2. Market Revenue and Forecast, by End User (2016-2030)
10.2.5.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.2.6.2. Market Revenue and Forecast, by End User (2016-2030)
10.2.6.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.2.7.2. Market Revenue and Forecast, by End User (2016-2030)
10.2.7.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.3.APAC
10.3.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.3.2. Market Revenue and Forecast, by End User (2016-2030)
10.3.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.3.4.2. Market Revenue and Forecast, by End User (2016-2030)
10.3.4.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.3.5.2. Market Revenue and Forecast, by End User (2016-2030)
10.3.5.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.3.6.2. Market Revenue and Forecast, by End User (2016-2030)
10.3.6.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.3.7.2. Market Revenue and Forecast, by End User (2016-2030)
10.3.7.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.4.MEA
10.4.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.4.2. Market Revenue and Forecast, by End User (2016-2030)
10.4.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.4.4.2. Market Revenue and Forecast, by End User (2016-2030)
10.4.4.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.4.5.2. Market Revenue and Forecast, by End User (2016-2030)
10.4.5.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.4.6.2. Market Revenue and Forecast, by End User (2016-2030)
10.4.6.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.4.7.2. Market Revenue and Forecast, by End User (2016-2030)
10.4.7.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.5.Latin America
10.5.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.5.2. Market Revenue and Forecast, by End User (2016-2030)
10.5.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.5.4.2. Market Revenue and Forecast, by End User (2016-2030)
10.5.4.3. Market Revenue and Forecast, by Disorder (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Procedure (2016-2030)
10.5.5.2. Market Revenue and Forecast, by End User (2016-2030)
10.5.5.3. Market Revenue and Forecast, by Disorder (2016-2030)
Chapter 11. Company Profiles
11.1.University of Pittsburgh Medical Center
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2.Rutland Medical Center
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3.Huntington Hospital
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4.Washington Hospital Healthcare System
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5.The Ottawa Hospital
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6.Michael's Hospital
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7.Charité - Universitätsmedizin Berlin
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8.Ipswich Hospital
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9.Apollo Hospitals Enterprise Limited
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. HealthCare Global Enterprises Ltd.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1.Primary Research
12.2.Secondary Research
12.3.Assumptions
Chapter 13. Appendix
13.1.About Us
13.2.Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers